科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Center for Cellular Immunotherapies,
Perelman School of Medicine,
Parker Institute for Cancer Immunotherapy,
Center for Cellular Immunotherapies, Perelman School of Medicine
Sangya Agarwal has not added Biography.
If you are Sangya Agarwal and would like to personalize this page please email our Author Liaison for assistance.
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody.
Cancer immunology, immunotherapy : CII Dec, 2017 | Pubmed ID: 28819703
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.
Human vaccines & immunotherapeutics 04, 2020 | Pubmed ID: 31799896
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.
Cancer discovery 04, 2020 | Pubmed ID: 32001516
Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.
Cancer discovery 06, 2020 | Pubmed ID: 32303509
LFA-1 signals to promote actin polymerization and upstream migration in T cells.
Journal of cell science Sep, 2020 | Pubmed ID: 32907931
University of Pennsylvania
Sangya Agarwal*,1,2,
Nils Wellhausen*,1,2,
Bruce L. Levine1,2,
Carl H. June1,2
1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania,
2Parker Institute for Cancer Immunotherapy, University of Pennsylvania
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。